Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-08-08
2008-09-02
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07419988
ABSTRACT:
The present invention relates to a compound represented by Formula (I):and pharmaceutically acceptable salts. Compounds of the present invention inhibit Aurora kinase, making them especially suitable for the treatment of a number of diseases, including solid tumor cancers and hematological cancers.
REFERENCES:
patent: 6770643 (2004-08-01), Cox et al.
patent: 7282588 (2007-10-01), Dhanak et al.
patent: 2006/0211678 (2006-09-01), Ahmed et al.
patent: WO2007/076423 (2007-07-01), None
Dhanak Dashyant
Newlander Kenneth Allen
Chandrakumar Nizal S
Majarian William
Seaman D. Margaret
SmithKline Beecham Corp
Venetianer Stephen
LandOfFree
Azaindole inhibitors of aurora kinases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azaindole inhibitors of aurora kinases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azaindole inhibitors of aurora kinases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3973559